Form 8-K - Current report:
SEC Accession No. 0001104659-25-016345
Filing Date
2025-02-24
Accepted
2025-02-24 06:45:32
Documents
15
Period of Report
2025-02-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm257217d1_8k.htm   iXBRL 8-K 28696
2 EXHIBIT 99.1 tm257217d1_ex99-1.htm EX-99.1 4139
3 GRAPHIC tm257217d1_ex99-1img001.jpg GRAPHIC 11051
  Complete submission text file 0001104659-25-016345.txt   225367

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zura-20250224.xsd EX-101.SCH 3012
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20250224_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20250224_pre.xml EX-101.PRE 22357
17 EXTRACTED XBRL INSTANCE DOCUMENT tm257217d1_8k_htm.xml XML 3804
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 25654125
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)